Contents

Current Alzheimer Research, Volume 5 - Number 1

Editorial [ Progress of ‘Current Alzheimer Research’ and Update on Roles of Lipids, Estrogen,Neurotrophins and Cytokines in Alzheimers Disease ]

, 5(1): 1 - 3

Debomoy K. Lahiri


DOI: 10.2174/156720508783884639




Lipids as Key Players in Alzheimer Disease - Alterations in Metabolism and Genetics

, 5(1): 4 - 14

Ferhan Girgin Sagin and Eser Yildirim Sozmen


DOI: 10.2174/156720508783884648




Functional Role of Lipoprotein Receptors in Alzheimers Disease

, 5(1): 15 - 25

Claus U. Pietrzik and Sebastian Jaeger


DOI: 10.2174/156720508783884675




Detoxification Depot for β -Amyloid Peptides

, 5(1): 26 - 32

Pazhani Sundaram, Ranjini K. Sundaram, Chinnaswamy Kasinathan and Stanley Stein


DOI: 10.2174/156720508783884684




Pro-inflammatory Cytokines Modulate Glial Apolipoprotein E Secretion

, 5(1): 33 - 37

Judes Poirier, Rosanne Aleong and Jean-Francois Blain


DOI: 10.2174/156720508783884666




Neurotrophins - From Pathophysiology to Treatment in Alzheimers Disease

, 5(1): 38 - 44

Rainer Hellweg, Olaf Schulte-Herbruggen and Maria C. Jockers-Scherubl


DOI: 10.2174/156720508783884620




Levels of Estrogen Receptors α and β in Frontal Cortex of Patients with Alzheimers Disease: Relationship to Mini-Mental State Examination Scores

, 5(1): 45 - 51

Jeremiah F. Kelly, Julia L. Bienias, Avni Shah, Kathleen A. Meeke, Julie A. Schneider, Edwin Soriano and David A. Bennett


DOI: 10.2174/156720508783884611




Differentiating the Dementias. Revisiting Synucleinopathies and Tauopathies

, 5(1): 52 - 60

Catherine Hickey, Terry Chisholm, Michael J. Passmore, Jonathon Darcy O'Brien and Jennifer Johnston


DOI: 10.2174/156720508783884657




Prevalence of Neuropsychiatric Symptoms in Alzheimers Disease and Vascular Dementia

, 5(1): 61 - 69

Manuel Fernandez-Martinez, Jessica Castro, Ana Molano, Juan Jose Zarranz, Rosa Monica Rodrigo and Rafael Ortega


DOI: 10.2174/156720508783884585




Risk Factors of Alzheimers Disease Among Iranian Population

, 5(1): 70 - 72

Mahshid Foroughan, Zia Ghaemmagham Farahani, Maryam Shariatpanahi, Mehrak Vaezinejad, Ahmad Ali Akbari Kamerani and Mehrdad Sheikhvatan


DOI: 10.2174/156720508783884594




Rofecoxib in Patients with Mild Cognitive Impairment: Further Analyses of Data from a Randomized, Double-Blind, Trial

, 5(1): 73 - 82

Paul S. Aisen, Leon J. Thal, Steven H. Ferris, Christopher Assaid, Michael L. Nessly, Michael J. Giuliani, Christopher R. Lines, Barbara A. Norman and William Z. Potter


DOI: 10.2174/156720508783884602




Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial

, 5(1): 83 - 89

Anton P. Porsteinsson, George T. Grossberg, Jacobo Mintzer and Jason T. Olin


DOI: 10.2174/156720508783884576




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science